Inventor
Mark Mills
Inventor
GB
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds44%
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
PatentTitleYear
12,331,029Orexin 1 receptor antagonists202512,240,825Oxexin 1 receptor antagonists202512,180,186Quaternary indazole glucocorticoid receptor antagonists202412,098,144Piperazine indazole glucocorticoid receptor antagonists202412,098,141Bicyclic indazole glucocorticoid receptor antagonists202411,993,613Thiazolo[5,4-b]pyridine MALT-1 inhibitors202411,787,780Quaternary indazole glucocorticoid receptor antagonists2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to CORCEPT THERAPEUTICS INC (4)· patent assignee history
2023–2025Based in GB· patent location history
2024Patents assigned to ABBVIE INC (1)· patent assignee history
2025Patents assigned to NXERA PHARMA UK LTD (2)· patent assignee history
2025Patents assigned to HEPTARES THERAPEUTICS LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CORCEPT THERAPEUTICS INC | 4 | 2023–2024 |
| NXERA PHARMA UK LTD | 2 | 2025 |
| ABBVIE INC | 1 | 2024 |
| HEPTARES THERAPEUTICS LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 7 | 2023–2025 |